Hong Kong News

Nonpartisan, Noncommercial, unconstrained.
Sunday, Feb 05, 2023

'Functional cure' in the works for hepatitis B

'Functional cure' in the works for hepatitis B

Some 570,000 hepatitis B carriers in Hong Kong may be freed from life-long medication and see their liver cancer and cirrhosis risks reduced in the next decade with University of Hong Kong researchers completing development of a new therapy to achieve "functional cure."
Gastroenterology and hepatology chief and research leader Yuen Man-fung said hepatitis B sufferers here rely on life-long oral medication to suppress their viral load.

If their conditions are untreated or do not improve, one in three would develop complications, including liver cirrhosis and cancer. Every year, 820,000 lives are estimated to be claimed by hepatitis B worldwide.

Yuen said the goal of the drug is to buy time to achieve a "functional cure" to suppress patients' viral load to a minimal, or even undetectable, level.

Antigens on the surface of hepatitis B viruses - which "hypnotize" patients' immune system to favor viral replication - will also be suppressed to a minimal level.

In the absence of the antigen, the immune system will "wake up" and fight the virus itself, and patients will no longer have to take medication for life.

Yuen said his team has taken the drug to phase two clinical trials and found around one in 10 recipients saw lower viral loads upon receiving a dose of 300mg of the drug per week over a period of 24 weeks.

Among test subjects with lower viral loads to begin with, up to one in four saw consistently lowered viral levels. After 24 weeks, 80 to 90 percent of them no longer require lifelong medications.

He said a phase three trial will be conducted and that it will take at least three to five more years to further assess the drug's effectiveness and safety before it can be approved for full clinical use.

Yuen said his team will also focus on combining different medications to push the "functional cure" success rate to 30 percent.

He hopes the final product will consist of no more than three types of medications, and that patients only need to take them for two years or less.

He said HKU currently takes part in over 80 percent of international hepatitis B trials - including 58 over the past eight years - proving its leading position in the field.
Newsletter

Related Articles

Hong Kong News
Close
0:00
0:00
Charlie Munger, calls for a ban on cryptocurrencies in the US, following China's lead
Hong Kong airlines taking bold action after the years of pandemic lockdown and travel restrictions, to make Hong Kong great again
EU found a way to use frozen Russian funds
First generation unopened iPhone set to fetch more than $50,000 at auction.
WARNING GRAPHIC CONTENT - US Memphis Police murdering innocent Tyre Nichols
Almost 30% of professionals say they've tried ChatGPT at work
Interpol seeks woman who ran elaborate exam cheating scam in Singapore
Chinese search giant Baidu to launch ChatGPT like AI chatbot.
What is ChatGPT?
Bill Gates is ‘very optimistic’ about the future: ‘Better to be born 20 years from now...than any time in the past’
China is opening up for foreign investors.
Tesla reported record profits and record revenues for 2022
Prince Andrew and Virginia Giuffre Photo Is Fake: Ghislaine Maxwell
Moonwalker Buzz Aldrin Gets Married On His 93rd Birthday
Federal Reserve Probes Goldman’s Consumer Business
China's first population drop in six decades
Microsoft is finalising plans to become the latest technology giant to reduce its workforce during a global economic slowdown
China's foreign ministry branch in Hong Kong urges British gov't to stop the biased and double standards Hong Kong report
China relaxes 'red lines' on property sector borrowing in policy pivot
Tesla slashes prices globally by as much as 20 percent
Japan prosecutors indict man for ex-PM Shinzo Abe murder
Vietnam removes two deputy PMs amid anti-corruption campaign
1.4 Million Copies Of Prince Harry's Memoir 'Spare' Sold On 1st Day In UK
After Failing To Pay Office Rent, Twitter May Sell User Names
FIFA president questioned by prosecutors
Britain's Sunak breaks silence and admits using private healthcare
Hype and backlash as Harry's memoir goes on sale. Unnamed royal source says prince 'kidnapped by cult of psychotherapy and Meghan'
China’s recovery could add 1% to Australia’s GDP: JPMorgan 
Saudi Arabia set to overtake India as fastest-growing major economy this year 
China vows to strengthen financial support for enterprises: official
International medical experts speak out against COVID-19 restrictions on China
2 Billion People To Travel In China's "Great Migration" Over Next 40 Days
Google and Facebook’s dominance in digital ads challenged by rapid ascent of Amazon and TikTok
Flight constraints expected to weigh on China travel rebound
Billionaire Jack Ma relinquishes control of Ant Group
FTX fraud investigators are digging deeper into Sam Bankman-Fried's inner circle – and reportedly have ex-engineer Nishad Singh in their sights
Teslas now over 40% cheaper in China than US
TikTok CEO Plans to Meet European Union Regulators
UK chaos: Hong Kong emigrants duped by false prospectus
China seeks course correction in US ties but will fight ‘all forms of hegemony’, top diplomat Wang Yi says
China will boost spending in 2023
African traders welcome end of China’s Covid travel curbs
France has banned the online sale of paracetamol until February, citing ongoing supply issues
Japan reportedly to give families 1 million yen per child to move out of Tokyo
Will Canada ever become a real democracy?
Hong Kong property brokerages slash payrolls in choppy market
U.S. Moves to Seize Robinhood Shares, Silvergate Accounts Tied to FTX
Effect of EU sanctions on Moscow is ‘less than zero’ – Belgian MEP
Coinbase to Pay $100 Million in Settlement With New York Regulator
Preparations begin for Spring Festival travel rush
×